ES2036702T3 - Procedimiento para la preparacion de derivados de cefalosporinas. - Google Patents

Procedimiento para la preparacion de derivados de cefalosporinas.

Info

Publication number
ES2036702T3
ES2036702T3 ES198888402527T ES88402527T ES2036702T3 ES 2036702 T3 ES2036702 T3 ES 2036702T3 ES 198888402527 T ES198888402527 T ES 198888402527T ES 88402527 T ES88402527 T ES 88402527T ES 2036702 T3 ES2036702 T3 ES 2036702T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
cephalosporin derivatives
derivatives
refers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888402527T
Other languages
English (en)
Inventor
Bernard Labeeuw
Ali Salhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elf Sanofi SA
Original Assignee
Elf Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elf Sanofi SA filed Critical Elf Sanofi SA
Application granted granted Critical
Publication of ES2036702T3 publication Critical patent/ES2036702T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/32—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS DE CEFALOSPOLINAS DE FORMULA DESCRITA EN LA INVENCION. SE REFIERE IGUALMENTE A UN PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN E INTERMEDIARIOS DE SINTESIS. DICHOS DERIVADOS PRESENTAN PROPIEDADES FARMACEUTICAS MEJORADAS.
ES198888402527T 1987-10-08 1988-10-06 Procedimiento para la preparacion de derivados de cefalosporinas. Expired - Lifetime ES2036702T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8713925A FR2621589B1 (fr) 1987-10-08 1987-10-08 Derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
ES2036702T3 true ES2036702T3 (es) 1993-06-01

Family

ID=9355637

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888402527T Expired - Lifetime ES2036702T3 (es) 1987-10-08 1988-10-06 Procedimiento para la preparacion de derivados de cefalosporinas.

Country Status (19)

Country Link
US (1) US5079241A (es)
EP (1) EP0311521B1 (es)
JP (1) JPH0637502B2 (es)
KR (1) KR970004044B1 (es)
AR (1) AR246271A1 (es)
AT (1) ATE74607T1 (es)
AU (2) AU612414B2 (es)
DE (1) DE3869895D1 (es)
DK (1) DK555288A (es)
ES (1) ES2036702T3 (es)
FI (1) FI89715C (es)
FR (1) FR2621589B1 (es)
GR (1) GR3005122T3 (es)
IE (1) IE61508B1 (es)
IL (2) IL103721A (es)
NO (1) NO171275C (es)
NZ (1) NZ226487A (es)
PT (1) PT88694B (es)
ZA (1) ZA887546B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4282699B2 (ja) 2006-09-01 2009-06-24 株式会社東芝 半導体装置
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4138555A (en) * 1971-05-14 1979-02-06 Glaxo Laboratories, Limited (6R,7R)-7-[2-aryl-2-(etherified oximino)acetamido]-3-carbamoyloxymethylceph-3-em-4-carboxylic acid 1-oxides
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
JPS5760345B2 (es) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
US4668783A (en) * 1974-12-19 1987-05-26 Takeda Chemical Industries, Ltd. Thiazolylacetamido cephalosporin compounds
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
US4871860A (en) * 1976-04-12 1989-10-03 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-caroxylic acid compounds and processes for the preparation thereof
US4493833A (en) * 1976-04-12 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
US4304770A (en) * 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4331664A (en) * 1976-04-12 1982-05-25 Fujisawa Pharmaceutical Co., Ltd. Syn isomer of 7-[2-cyclo(lower) alkoxyimino-2-(2-amino-or substituted aminothiazol-4-yl)acetamido]-3-lower alkanoyloxymethyl or heterocyclicthiomethyl-3-cephem-4-carboxylic acid compounds
US4804752A (en) * 1976-04-12 1989-02-14 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4364943A (en) * 1976-04-12 1982-12-21 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 7-[2-alkoxyimino-2-(2-amino-alkanoylamino-or haloalkanoylamino-thiazol-4-yl) acetamids]-3-[hexanoyl-, or phenylalkanoyl-oxymethyl or benzothiazolylthiomethyl]-3-cephem-4-carboxylic acid
DE2760484C2 (es) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4655166A (en) * 1979-12-26 1987-04-07 Hitachi, Ltd. Apparatus for preventing oscillation of running strip
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
FR2570702B1 (fr) * 1984-09-27 1987-01-09 Sanofi Sa Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
FR2607135B1 (fr) * 1986-11-20 1989-04-28 Sanofi Sa Nouveaux derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA884093B (en) * 1987-06-16 1989-04-26 Hoffmann La Roche Acyl derivatives

Also Published As

Publication number Publication date
PT88694A (pt) 1988-11-01
AU2349588A (en) 1989-04-13
KR970004044B1 (ko) 1997-03-24
JPH0637502B2 (ja) 1994-05-18
AU637915B2 (en) 1993-06-10
IL87975A0 (en) 1989-03-31
GR3005122T3 (es) 1993-05-24
ZA887546B (en) 1989-06-28
DK555288A (da) 1989-04-09
IL103721A (en) 1994-06-24
NO171275B (no) 1992-11-09
FI884614A0 (fi) 1988-10-07
DE3869895D1 (de) 1992-05-14
FI89715B (fi) 1993-07-30
NO884486L (no) 1989-04-10
NZ226487A (en) 1990-08-28
IL87975A (en) 1993-04-04
AU612414B2 (en) 1991-07-11
FR2621589A1 (fr) 1989-04-14
AU7945191A (en) 1991-09-12
PT88694B (pt) 1992-12-31
FR2621589B1 (fr) 1990-03-02
IE61508B1 (en) 1994-11-02
IE883046L (en) 1989-04-08
KR890006656A (ko) 1989-06-15
US5079241A (en) 1992-01-07
NO884486D0 (no) 1988-10-07
DK555288D0 (da) 1988-10-04
FI884614A (fi) 1989-04-09
EP0311521B1 (fr) 1992-04-08
JPH01128985A (ja) 1989-05-22
FI89715C (fi) 1993-11-10
EP0311521A1 (fr) 1989-04-12
AR246271A1 (es) 1994-07-29
ATE74607T1 (de) 1992-04-15
NO171275C (no) 1993-02-17

Similar Documents

Publication Publication Date Title
NO914092D0 (no) Fremgangsmaate for fremstilling av mercaptoacetylamidderivater
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES525653A0 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
MX9524A (es) Derivados de catecol y procedimiento para su preparacion y composiciones que los contienen.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
IT1146175B (it) Procedimento per la preparazione di derivati di resorcinolo
MX9202544A (es) Compuestos de diaminoftalimidas substituidas y analogas, procedimiento para su preparacion y preparados farmaceuticos que los contienen.
ES2108772T3 (es) Derivados de aminofosfonato substituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX168030B (es) Procedimiento para la preparacion de derivados de alcano y alcoxialcano
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2037682T3 (es) Procedimiento para la preparacion de composiciones farmaceuticas empleando quitosanos metilados.
ES2036702T3 (es) Procedimiento para la preparacion de derivados de cefalosporinas.
ES538982A0 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX166685B (es) Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas
SV1998000013A (es) Derivados de 5-aroilnaftaleno ref.-ran 4070\115

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 311521

Country of ref document: ES